Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shishi Yi-Qi Bu-Shen Tong-Luo is a Traditional Chinese Medicine (TCM) formula developed by the Shanghai Ninth People's Hospital Huangpu Branch, rooted in the "Shi-style" (Shishi) orthopedic tradition. The formula is designed to tonify Qi (Yi-Qi), reinforce the kidney (Bu-Shen), and dredge the collaterals (Tong-Luo), which are traditional therapeutic principles aimed at promoting bone healing and restoring joint function. It is primarily investigated as an adjunctive therapy for patients recovering from distal radius fractures, specifically to prevent or treat wrist joint stiffness and adhesions. The medication is typically administered orally in the form of granules or decoctions, often in combination with physical manipulation or surgical adhesion release procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shishi Yi-Qi Bu-Shen Tong-Luo.